Late-onset retinal degeneration pathology due to mutations in CTRP5 is mediated through HTRA1.


Journal

Aging cell
ISSN: 1474-9726
Titre abrégé: Aging Cell
Pays: England
ID NLM: 101130839

Informations de publication

Date de publication:
12 2019
Historique:
received: 05 03 2019
revised: 13 05 2019
accepted: 16 06 2019
pubmed: 7 8 2019
medline: 15 9 2020
entrez: 7 8 2019
Statut: ppublish

Résumé

Late-onset retinal degeneration (L-ORD) is an autosomal dominant macular degeneration characterized by the formation of sub-retinal pigment epithelium (RPE) deposits and neuroretinal atrophy. L-ORD results from mutations in the C1q-tumor necrosis factor-5 protein (CTRP5), encoded by the CTRP5/C1QTNF5 gene. To understand the mechanism underlying L-ORD pathology, we used a human cDNA library yeast two-hybrid screen to identify interacting partners of CTRP5. Additionally, we analyzed the Bruch's membrane/choroid (BM-Ch) from wild-type (Wt), heterozygous S163R Ctrp5 mutation knock-in (Ctrp5

Identifiants

pubmed: 31385385
doi: 10.1111/acel.13011
pmc: PMC6826137
doi:

Substances chimiques

C1QTNF5 protein, human 0
Collagen 9007-34-5
High-Temperature Requirement A Serine Peptidase 1 EC 3.4.21.-
HTRA1 protein, human EC 3.4.21.-

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13011

Subventions

Organisme : Edward N. & Della L. Thome memorial foundation
Pays : International
Organisme : The Foundation Fighting Blindness
Pays : International
Organisme : NIDDK NIH HHS
ID : R01 DK041737
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY025693
Pays : United States
Organisme : Medical Research Council
ID : MC_UU_00007/10
Pays : United Kingdom
Organisme : Research to Prevent Blindness
Pays : International
Organisme : NIH HHS
ID : NIH-EY21237
Pays : United States
Organisme : NIH HHS
ID : P30-EY22589
Pays : United States

Informations de copyright

© 2019 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.

Références

Arch Ophthalmol. 2002 Mar;120(3):376-9
pubmed: 11879143
EBioMedicine. 2018 Jan;27:258-274
pubmed: 29269042
Bone. 2005 Sep;37(3):323-36
pubmed: 15993670
Invest Ophthalmol Vis Sci. 1996 Aug;37(9):1772-82
pubmed: 8759344
J Biol Chem. 2002 Sep 13;277(37):34150-60
pubmed: 12091393
Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6971-80
pubmed: 26513502
Clin Genet. 2017 Jan;91(1):38-45
pubmed: 27160483
Invest Ophthalmol Vis Sci. 2014 May 22;55(6):3842-50
pubmed: 24854852
Neuromuscul Disord. 2002 Oct;12 Suppl 1:S125-41
pubmed: 12206807
Hum Mol Genet. 2003 Oct 15;12(20):2657-67
pubmed: 12944416
Front Immunol. 2015 Jun 29;6:317
pubmed: 26175731
Prog Retin Eye Res. 2019 May;70:55-84
pubmed: 30572124
Surv Ophthalmol. 2018 Nov - Dec;63(6):782-815
pubmed: 29859199
J Biol Chem. 2006 Mar 10;281(10):6124-9
pubmed: 16377621
PLoS One. 2011;6(11):e27433
pubmed: 22110650
Arch Ophthalmol. 2000 Jan;118(1):85-92
pubmed: 10636420
Ophthalmology. 2000 Dec;107(12):2256-66
pubmed: 11097607
Trends Biochem Sci. 2013 Aug;38(8):378-85
pubmed: 23768628
Science. 2003 Oct 31;302(5646):819-22
pubmed: 14593166
Mol Cancer Res. 2010 Sep;8(9):1248-60
pubmed: 20671064
Annu Rev Neurosci. 2001;24:1121-59
pubmed: 11520930
Invest Ophthalmol Vis Sci. 2010 Jul;51(7):3379-86
pubmed: 20207970
J Gerontol A Biol Sci Med Sci. 2001 Nov;56(11):B459-67
pubmed: 11682566
J Cell Sci. 2018 Aug 28;132(4):
pubmed: 30082277
Biochem J. 2004 Aug 1;381(Pt 3):895-904
pubmed: 15101818
Biochem J. 2008 Dec 1;416(2):161-77
pubmed: 18783346
Arch Biochem Biophys. 2002 Jan 15;397(2):407-13
pubmed: 11795901
Nat Rev Mol Cell Biol. 2011 Mar;12(3):152-62
pubmed: 21326199
J Biol Chem. 2004 Jul 16;279(29):30469-73
pubmed: 15123717
Ophthalmic Genet. 2018 Dec;39(6):763-770
pubmed: 30451557
J Biol Chem. 2009 Oct 2;284(40):27352-9
pubmed: 19657146
Sci Rep. 2017 Nov 1;7(1):14804
pubmed: 29093542
J Struct Biol. 2014 Apr;186(1):86-94
pubmed: 24531000
Retina. 2015 May;35(5):989-98
pubmed: 25627090
Aging Cell. 2019 Dec;18(6):e13011
pubmed: 31385385
Dev Dyn. 2006 Dec;235(12):3448-55
pubmed: 17072861
Arch Ophthalmol. 1999 Mar;117(3):329-39
pubmed: 10088810
Retina. 2016 Dec;36(12):2348-2356
pubmed: 27388725
Cold Spring Harb Perspect Biol. 2011 Nov 01;3(11):a007492
pubmed: 21825021
Int J Biochem Cell Biol. 2004 Dec;36(12):2519-30
pubmed: 15325589
J Histochem Cytochem. 2003 Oct;51(10):1279-84
pubmed: 14500695
Hum Mol Genet. 2011 May 15;20(10):2000-14
pubmed: 21349921
J Struct Biol. 2012 Dec;180(3):439-46
pubmed: 22892318
Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):13067-72
pubmed: 12242346
Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5514-21
pubmed: 17122143
Science. 2006 Nov 10;314(5801):992-3
pubmed: 17053109
Br J Ophthalmol. 2009 Mar;93(3):284-9
pubmed: 19098033
Hum Mol Genet. 2006 May 15;15(10):1680-9
pubmed: 16600989
Aging Cell. 2018 Aug;17(4):e12710
pubmed: 29730901
Nature. 1989 Jul 20;340(6230):245-6
pubmed: 2547163
J Biol Chem. 1998 Dec 18;273(51):34406-12
pubmed: 9852107
Proc Natl Acad Sci U S A. 2011 Aug 30;108(35):14578-83
pubmed: 21844367
Hum Mol Genet. 2018 Mar 1;27(5):929-940
pubmed: 29346644
Nucleic Acids Res. 2016 Jan 4;44(D1):D294-300
pubmed: 26615199
Hum Mol Genet. 2007 Oct 15;16(20):2411-22
pubmed: 17666404
Exp Eye Res. 1997 Jul;65(1):117-26
pubmed: 9237872
Vision Res. 2008 Feb;48(5):685-9
pubmed: 18207215
Nat Struct Mol Biol. 2011 Mar;18(3):386-8
pubmed: 21297635
Oncogene. 2004 Feb 26;23(8):1636-44
pubmed: 14716297
Immunobiology. 2007;212(4-5):253-66
pubmed: 17544811
Invest Ophthalmol Vis Sci. 2005 Sep;46(9):3363-71
pubmed: 16123441
Prog Retin Eye Res. 2016 Jul;53:70-106
pubmed: 27173377
Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5505-13
pubmed: 17122142
Sci Rep. 2017 Sep 22;7(1):12147
pubmed: 28939808
FEMS Microbiol Lett. 2004 Aug 15;237(2):279-88
pubmed: 15321674
Nat Cell Biol. 2004 Nov;6(11):1054-61
pubmed: 15516999
Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9578-82
pubmed: 1946372
Science. 2006 Nov 10;314(5801):989-92
pubmed: 17053108
J Biol Chem. 2012 Jun 15;287(25):20931-41
pubmed: 22535953
Adv Exp Med Biol. 2016;854:53-8
pubmed: 26427393
Mol Vis. 2015 Mar 13;21:273-84
pubmed: 25814825

Auteurs

Anil Chekuri (A)

Shiley Eye Institute, University of California San Diego, San Diego, CA, USA.

Katarzyna Zientara-Rytter (K)

Division of Biological Sciences, University of California San Diego, San Diego, CA, USA.

Angel Soto-Hermida (A)

Shiley Eye Institute, University of California San Diego, San Diego, CA, USA.

Shyamanga Borooah (S)

Shiley Eye Institute, University of California San Diego, San Diego, CA, USA.

Marina Voronchikhina (M)

Shiley Eye Institute, University of California San Diego, San Diego, CA, USA.

Pooja Biswas (P)

Shiley Eye Institute, University of California San Diego, San Diego, CA, USA.

Virender Kumar (V)

Shiley Eye Institute, University of California San Diego, San Diego, CA, USA.

David Goodsell (D)

Integrative Structural and Computational Biology (ISCB), Scripps Research Institute, San Diego, CA, USA.

Caroline Hayward (C)

Medical Research Council Human Genetics Unit, Medical Research Council Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.

Peter Shaw (P)

Shiley Eye Institute, University of California San Diego, San Diego, CA, USA.

Chloe Stanton (C)

Medical Research Council Human Genetics Unit, Medical Research Council Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.

Donita Garland (D)

Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.

Suresh Subramani (S)

Division of Biological Sciences, University of California San Diego, San Diego, CA, USA.

Radha Ayyagari (R)

Shiley Eye Institute, University of California San Diego, San Diego, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH